Skip to main content
Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · IEX Real-Time Price · USD
28.02
-0.22 (-0.78%)
At close: Apr 26, 2024, 4:00 PM
27.47
-0.55 (-1.96%)
After-hours: Apr 26, 2024, 5:11 PM EDT

Q32 Bio Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Q32 Bio stock have an average target of 47.5, with a low estimate of 45 and a high estimate of 50. The average target predicts an increase of 69.52% from the current stock price of 28.02.

Analyst Consensus: Buy
Target Low Average Median High
Price $45 $47.5 $50 $50
Change +60.60% +69.52% +78.44% +78.44%

Analyst Ratings

The average analyst rating for Q32 Bio stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Apr '24
Strong Buy 0
Buy 2
Hold 0
Sell 0
Strong Sell 0
Total 2

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Jay Olson
Oppenheimer
 Oppenheimer
Buy
Initiates
$50
 Buy Initiates $50 +78.44% Apr 11, 2024
Christopher Raymond
Piper Sandler
 Piper Sandler
Buy
Initiates
$45
 Buy Initiates $45 +60.60% Apr 2, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
1.02M
from 1.16M
Decreased by -11.76%
Revenue Next Year
1.02M
from 1.02M
EPS This Year
-13.77
from -35.10
EPS Next Year
-12.87
from -13.77
Year 20192020202120222023202420252026
Revenue
1.67M2.70M33.97M3.21M1.16M1.02M1.02M2.04M
Revenue Growth
-68.70%62.18%1,157.25%-90.56%-63.97%-11.76%-100.00%
EPS
-44.46-50.40-31.14-1.62-35.10-13.77-12.87-11.92
EPS Growth
--------
No. Analysts -----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 2.1M 2.1M 2.1M
Avg 1.0M 1.0M 2.0M
Low n/a n/a 2.0M

Revenue Growth

Revenue Growth 202420252026
High
81.7%
105.9%
105.9%
Avg
-11.8%
-
100.0%
Low - -
92.2%

EPS Forecast

EPS 202420252026
High -14.18 -13.25 -12.27
Avg -13.77 -12.87 -11.92
Low -13.23 -12.37 -11.45

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.